Comment on

• Caplacizumab for Acquired Thrombotic Thrombocytopenic Purpura.

  Peyvandi F, Scully M, Kremer Hovinga JA, Cataland S, Knöbl P, Wu H, Artoni A, Westwood JP, Mansouri Taleghani M, Jilma B, Callewaert F, Ulrichts H, Duby C, Tersago D; TITAN Investigators. Peyvandi F, et al. N Engl J Med. 2016 Feb 11;374(6):511-22. doi: 10.1056/NEJMoa1505533. N Engl J Med. 2016. PMID: 26863353 Clinical Trial.
• Caplacizumab for Acquired Thrombotic Thrombocytopenic Purpura.

  Abdelghany MT, Baggett MV. Abdelghany MT, et al. N Engl J Med. 2016 Jun 23;374(25):2497. doi: 10.1056/NEJMc1603180. N Engl J Med. 2016. PMID: 27332912 No abstract available.